Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
Launched by WESTERN UNIVERSITY, CANADA · Sep 20, 2019
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Current pessary users (\> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
- • Are able to provide informed consent
- • Can perform self-care, i.e. removing and inserting the pessary themselves
- • Are willing to remove their pessary 2 days before the ultrasound examination date.
- Exclusion Criteria:
- • Inability to give informed consent
- • Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
- • History of pelvic radiation or surgery, (including hysterectomy)
- • Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
- • Inability to perform the Valsalva maneuver or pelvic floor contraction
- • Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
- • Lack of sensation at the pelvic floor.
- • Being pregnant at the time of the examination.
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials